Helicobacter pylori

Complete H. Pylori Genome Sequence Licensed

Published in Cancer Weekly, December 9th, 1996

Vaccine development partners OraVax, Inc., Cambridge, Massachusetts, and Pasteur Merieux Connaught have entered a research and licensing agreement with MedImmune, Gaithersburg, Maryland, and Human Genome Sciences (HGS), Rockville, Maryland.

Announced jointly by all four companies, OraVax and Pasteur Merieux Connaught have licensed the complete genome sequence of Helicobacter pylori for the development of vaccines against H. pylori. H. pylori is the bacterium which causes the majority of cases of duodenal and stomach ulcers and is a major risk factor for stomach cancer.

Under the terms of the agreement, OraVax and Pasteur Merieux...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-12-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry